Skip to main content
. 2005 Jan 24;2005(1):CD002738. doi: 10.1002/14651858.CD002738.pub2

Comparison 8. CFC‐BDP versus Placebo,on oral steroids: 400 mcg/d or less.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 FEV1 (% predicted) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
1.1 Children 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Adults 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 Children and Adults 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Daily dose of oral prednisiolone (mg) 2 63 Mean Difference (IV, Fixed, 95% CI) ‐6.31 [‐8.68, ‐3.94]
2.1 Children 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 Adults 2 63 Mean Difference (IV, Fixed, 95% CI) ‐6.31 [‐8.68, ‐3.94]
2.3 Children and Adults 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Reduction in daily dose of oral prednisolone (mg) 2 45 Mean Difference (IV, Fixed, 95% CI) ‐4.91 [‐5.88, ‐3.94]
3.1 Children 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 Adults 2 45 Mean Difference (IV, Fixed, 95% CI) ‐4.91 [‐5.88, ‐3.94]
3.3 Children and Adults 0 0 Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Daytime asthma symptom score 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
4.1 Children 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.2 Adults 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.3 Children and Adults 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Night‐time asthma symptom score 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
5.1 Children 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.2 Adults 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
5.3 Children and Adults 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Plasma cortisol (mmol/L) 1   Mean Difference (IV, Fixed, 95% CI) Totals not selected
6.1 Children 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.2 Adults 1   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 Children and Adults 0   Mean Difference (IV, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Oropharyngeal side‐effects 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
7.1 Children 0   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.2 Adults 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7.3 Children and Adults 0   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8 Oropharyngeal Candidiasis (No. of patients) 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
8.1 Children 0   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.2 Adults 1   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
8.3 Children and Adults 0   Risk Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Discontinuation of oral steroids (No. of patients) 4 152 Risk Ratio (M‐H, Random, 95% CI) 6.95 [2.79, 17.34]
9.1 Children 0 0 Risk Ratio (M‐H, Random, 95% CI) 0.0 [0.0, 0.0]
9.2 Adults 4 152 Risk Ratio (M‐H, Random, 95% CI) 6.95 [2.79, 17.34]
9.3 Children and Adults 0 0 Risk Ratio (M‐H, Random, 95% CI) 0.0 [0.0, 0.0]